English | Español

Biospace
Patient Daily | Dec 24, 2025

Experts discuss new treatment options for celiac disease beyond gluten-free diets
Patient Daily | Dec 24, 2025

AC Immune reports promising mid-stage results for Parkinson's immunotherapy
Patient Daily | Dec 24, 2025

Biopharma professionals urged to prioritize capability growth over job titles
Patient Daily | Dec 24, 2025

FDA reviews safety concerns over anti-RSV antibodies Beyfortus and Enflonsia

Patient Daily | Dec 24, 2025

Regeneron rebounds after setbacks with strong end-of-year performance
Patient Daily | Dec 24, 2025

Pfizer signals more deals ahead after Metsera acquisition

Patient Daily | Dec 24, 2025

FDA grants first priority voucher approval to USAntibiotics' Augmentin XR
Patient Daily | Dec 24, 2025

Pfizer expands obesity portfolio with new licensing deal; FDA faces leadership changes

Trending
+ Marketing
A. K. Abreu | Jun 9, 2026

Patient in 5.0 Google review: Gulf Coast Breathe Free Sinus & Allergy Centers ‘changed my life’
Patient Daily | Jun 5, 2026

National Breathe Free donates $175,000 to support shelter for Tampa Bay families
+ Regulatory
Patient Daily News Service | Jun 9, 2026

New colon cancer blood test wins Medicare coverage, but trails stool-based screening in detecting precancerous lesions
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

FDA rare disease framework faces uncertainty after leadership departures